Overview:
The Senior Manager, R&D Quality Assurance independently performs the R&D QA Program Lead role for assigned clinical studies, providing Clinical Quality Assurance oversight in accordance with study protocols, company procedures, GCP requirements, and applicable local and international regulations. The role leads and supports quality oversight, audit, and inspection-readiness activities and works cross-functionally to identify, assess, mitigate, and escalate quality and compliance risks. The Senior Manager also provides guidance and oversight to junior R&D QA staff, as applicable, and supports continuous improvement activities within R&D Quality Assurance.
This is a hybrid role that can be based in Cambridge, MA; Philadelphia, PA; or Maidenhead, UK, with three days per week onsite.
Key Responsibilities:
- Independently perform the R&D QA Program Lead role for assigned clinical studies, providing Clinical Quality Assurance oversight in accordance with study protocols, company procedures, GCP requirements, and applicable local and international regulations, with escalation to the GCP QA Director as appropriate.
- Provide quality oversight for assigned clinical studies, including identification, assessment, mitigation, and escalation of quality and compliance risks and support for the investigation and resolution of Quality Events and CAPAs.
- Lead and support GCP audit activities, including investigator site, vendor, study, and process audits, as applicable, and ensure audit observations and associated corrective and preventive actions are appropriately addressed.
- Lead inspection-readiness activities for assigned clinical studies, including coordination of QA and cross-functional activities, identification and mitigation of potential inspection risks, and preparation for FDA, EMA, PMDA, and other Health Authority inspections.
- Establish and maintain effective working relationships with internal Alnylam Expertise Area leads, study teams, vendors, and external partners to support study quality, compliance, and inspection-readiness activities.
- Maintain current knowledge of applicable global GCP regulations, regulatory guidance, and industry practices and support continuous improvement of R&D QA processes, procedures, and tools, as applicable.
- Provide guidance, coaching, and oversight to assigned junior R&D QA staff, as applicable, to support effective execution of assigned activities and continued development.
Qualifications:
- Bachelor’s degree, preferably life science (technology, biological science, pharmacy, or other health related discipline preferred) or equivalent qualification or clinical research experience. Master’s degree in a science, technology, or industry related discipline, preferred.
- Seven years’ experience in GCP Quality Assurance, or similar experience working in GCP and clinical trial that support pharmaceutical development.
- Experience in overseeing late phase clinical trials
- Experience in leading audits preferred.
- Experience supporting and leading inspections readiness efforts and direct inspection experience.
- Extensive experience working with different Quality Assurance functions, knowledge of Auditing, Clinical Supply Chain, Clinical Operations, Monitoring, Regulatory Affairs, Clinical Research, Drug Safety, Data Management, Programming and Statistics
- Strong working knowledge & knowledge of how to interpret GCP regulations as well as industry guidance (e.g., FDA, EMA, and other national agencies).
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
Before applying, please review Alnylam's Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.
Skills Required
- Bachelor's degree in life science, technology, biological science, pharmacy, health-related discipline, or equivalent qualification or clinical research experience
- Seven years of experience in GCP Quality Assurance or similar GCP and clinical trial experience supporting pharmaceutical development
- Experience overseeing late-phase clinical trials
- Experience leading audits
- Experience supporting and leading inspection-readiness efforts
- Direct inspection experience
- Extensive experience working with Quality Assurance, Auditing, Clinical Supply Chain, Clinical Operations, Monitoring, Regulatory Affairs, Clinical Research, Drug Safety, Data Management, Programming, and Statistics functions
- Strong knowledge of interpreting GCP regulations and industry guidance, including FDA and EMA requirements
- Master's degree in a science, technology, or industry-related discipline
Alnylam Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Alnylam Pharmaceuticals and has not been reviewed or approved by Alnylam Pharmaceuticals.
-
Healthcare Strength — Alnylam Pharmaceuticals offers Blue Cross Blue Shield medical coverage with a choice of a PPO or an HDHP, and it funds the HDHP’s HSA ($750 for individual coverage or $1,500 for family coverage). Dental, vision, mental-health resources, and company-paid life and disability insurance round out a strong core health package.
-
Retirement Support — Alnylam Pharmaceuticals provides a Fidelity 401(k) with employer contributions, described as up to 6% when employees contribute at least 6% in one guide and a 4% match with automatic enrollment in another. Regardless of plan year, the availability of employer funding and auto-enrollment strengthens long-term savings support.
-
Wellbeing & Lifestyle Benefits — Alnylam Pharmaceuticals augments its package with up to $1,000 annually for eligible wellbeing expenses and up to 64 hours of paid Wellbeing Time. An Employee Assistance Program and other wellness resources further support day-to-day health and balance.
Alnylam Pharmaceuticals Insights
What We Do
Alnylam is a biopharmaceutical company pioneering RNA interference (RNAi) therapeutics, a gene-silencing approach designed to treat disease by disabling genes that cause or contribute to it. The company discovers, develops, and commercializes medicines based on RNAi, including approved therapies and a pipeline of investigational treatments. Its research targets both rare and prevalent diseases, with a mission to bring innovative medicines to patients.








